Key facts
- This page summarizes Douglas G. Forsyth's Form 4 filing for Inhibrx Biosciences, Inc. (INBX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 26 Aug 2024, 16:26.
Douglas G. Forsyth - 22 Aug 2024 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)
- Reporting relationship
- Director
- Issuer ticker
- INBX
- Reported as of
- 22 Aug 2024
- Net transaction value
- +$1,037,328
- SEC form
- 4
- Accepted by SEC
- 26 Aug 2024, 16:26:53 UTC
- Prior SEC filing
- 30 May 2024
- Next SEC filing
- 29 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kelly D. Deck, as attorney-in-fact for Douglas G. Forsyth
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Douglas G. Forsyth filed Form 4 for Inhibrx Biosciences, Inc. (INBX) on 26 Aug 2024.
Change
- Previous filing in this sequence was filed on 30 May 2024.
- Current net transaction value: +$1,037,328.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INBX
transaction
Common Stock
Purchase
- Transaction value
- $195,773
- Shares
- +15,188
- Change %
- +10%
- Price
- $12.89
- Shares after
- 164,752
- Date
- 22 Aug 2024
- Ownership
- By the Forsyth Family Trust Dated July 20, 2001
- Footnotes
- F1, F2
INBX
transaction
Common Stock
Purchase
- Transaction value
- $841,555
- Shares
- +59,812
- Change %
- +36%
- Price
- $14.07
- Shares after
- 224,564
- Date
- 23 Aug 2024
- Ownership
- By the Forsyth Family Trust Dated July 20, 2001
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares were purchased in multiple transactions at prices ranging from $12.80 to $13.00, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Footnote F2
The reporting person is a trustee of the Forsyth Family Trust Dated July 20, 2001 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Forsyth Family Trust Dated July 20, 2001.
Footnote F3
The shares were purchased in multiple transactions at prices ranging from $13.48 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.